Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Blood Biomarker Monitoring in Frontotemporal Lobar Degeneration: Neurofilament Surveillance Project (NSP)

NCT04516499 is registered in ClinicalTrials.gov with The Bluefield Project to Cure Frontotemporal Dementia as lead sponsor.

NCT NCT04516499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Blood Biomarker Monitoring in Frontotemporal Lobar Degeneration: Neurofilament Surveillance Project (NSP)
Lead sponsor
The Bluefield Project to Cure Frontotemporal Dementia
Phase
Observational
Overall status
Active, not recruiting
Start date
September 2, 2020
Completion date
February 28, 2027
Enrollment
342 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

frontotemporal dementia, frontotemporal lobar degeneration, ftd, ftd-grn, ftld